Vir Biotechnology CEO George Scangos speaks with CNBC from the 38th Annual J.P. Morgan Healthcare Conference.
Jim Cramer listed the J.P. Morgan's Healthcare Conference's best and worst performers judging by the stock market's reaction.
Jim Cramer listed the J.P. Morgan's Healthcare Conference's best and worst performers judging by the stock market's reaction.
CNBC's Meg Tirrell speaks with Leonard Schleifer, Regeneron CEO, about how the company will benefit from tax cuts, as well as pricing competition among drug companies.
CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.
Gilead CEO John Milligan speaks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about the company's M&A outlook, drug pricing and their work on cancer and Hepatitis C treatments.
At the J.P. Morgan Health Care Conference, Valeant CEO Joe Papa speaks with CNBC's Meg Tirrell about the turnaround in the company and their drug pricing strategy.
The full interview with Amicus CEO John Crowley.
The full interview with Allergan CEO Brent Saunders.
At the J.P. Morgan Health Care Conference, Johnson & Johnson CEO Alex Gorsky speaks with CNBC's Meg Tirrell about the impact of tax reform, his outlook for M&A in different business segments and competition with Amazon potentially in pharmaceuticals.
Francis deSouza, Illumina president and CEO, talks about what's driving the company's growth, the unveiling of its $20,000 desktop sequencer and the future of genome sequencing.
CNBC's Meg Tirrell reports details on the biggest health-care investing event of the year.